RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to decode therapeutically significant protein interfaces, revolutionizing the discovery of antibody-based drugs.
Total raised: $10M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.04.2018 | Series A | $10M | Paladin Ca... |
Mentions in press and media 6
| Date | Title | Description |
| 15.04.2018 | Vital Venture Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 15.04.2018 | Paladin Capital Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 15.04.2018 | Vital Venture Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 15.04.2018 | Paladin Capital Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 11.04.2018 | RubrYc Therapeutics Inks $10M Series A Round | SAN RAMON, CA, Biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures. >> Click here for more funding data on RubrYc Therapeutics >&... |
| 11.04.2018 | RubrYc Therapeutics Completes $10M Series A Financing | RubrYc Therapeutics, Inc., a San Ramon, CA-based biotherapeutics discovery company, closed a $10m Series A equity financing. The round was led by Third Point Ventures, with participation from Paladin Capital Group and Vital Venture Capital.... |